| Аудиторские |  Игры |  Промышленность |  Торговля |  Нефтеные |  Строительство |  Трейдеры |  Инвестиционные |  Юридические |  Оффшорные |  Автомобили |  Страхование |  Комуникации |  Химические компании |  Программы | 
 
Allergan, Incorporated (NYSE: AGN)

Price and Chart delayed at least 15 mintues.
Price $ 46.77 Change 0.00
Open 0.00 % Change 0.0%
Prev Close 46.77 Volume NA
Market Value 14 bil P/E Ratio 27.8
Bid 46.45 EPS 1.68
Ask 48.76 Dividend 0.20
High 0.00 Yield 0.4
Low 0.00 Shares Out 308 mil
52wk High 61.72 52wk Low 28.95
Industry: Drug Manufacturers - Other
Sector: Healthcare

AGN Profile

A health care company, which is focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to see more clearly, move more freely and express themselves more fully.

Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612
Phone: (714) 246-4500
Fax: (714) 246-4971
Web Site: www.allergan.com

AGN Wires Headlines

07.02.09  Final Glance: Medical Devices companies
07.02.09  Midday Glance: Medical Devices companies
07.02.09  Early Glance: Medical Devices companies
07.01.09  Final Glance: Medical Devices companies
07.01.09  Dutch banks still invest in arms companies-report

More AGN From Wires Headlines >

Forbes.com on AGN     RSS

  • Bet On Botox And Against Big-Budget Vanity
    • Cosmetic surgery has taken a hit during the recession, but the vane still find the dough for a few shots of Botox.

    AGN Press Releases

    06.18.09  Allergan Receives FDA Approval for OZURDEX(TM) Biodegradable, Injectable Steroid Implant with...

    More AGN Press Releases >

    AGN Ratios & Returns

    Price-to-sales 3.32
    Return on Equity 12.3
    Operating Margin 24.1
    Profit Margin 11.8%

    More AGN Ratios & Returns >

    AGN Financials

    Sales $4.334 bil
    Profits $0.5122 bil
    Assets $6.6797 bil
    Employees 8740.0
Allergan is ranked # 920 on the 2009 Forbes 2000 List

A D V E R T I S E M E N T




СМОТРЕТЬ
презентацию